INDIANAPOLIS, Indiana - After years of pressure, the drug manufacturer Eli Lilly will cap the cost of insulin at $35 a month for most customers in line with a provision in the Inflation Reduction Act of 2022. In January, this act imposed a $35 monthly cap on the out-of-pocket cost of insulin...